Skip to main content
. 2015 Nov 7;108(2):djv313. doi: 10.1093/jnci/djv313

Figure 2.

Figure 2.

Effect of T-DM1 on survival of mice with established human epidermal growth factor receptor 2–positive breast cancer brain metastases. Kaplan-Meier survival analysis of mice bearing BT474-Gluc (A) or MDA-MB-361-Gluc tumors (B) in the brain after treatment with control IgG, trastuzumab, or T-DM1 (15mg/kg) (n = 9–11). All statistical tests were two-sided.